Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01834625 · ClinicalTrials.gov registry record
Prognostic Value of Aβ Imaging in NPH Prior to Shunt Placement
A clinical trial, sponsored by Mayo Clinic.
- Terminated
- Registry status
- 2
- Enrollment target
NCT01834625: Clinical Trial study, sponsored by Mayo Clinic.
NCT01834625 is a clinical trial that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01834625 was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
In this pilot study the investigators shall prospectively in a blinded fashion evaluate with Aβ PET in patients committed to shunt surgery and then investigate the relationship of these biomarkers with outcome on gait, cognition and urinary control improvement in the short term (3 months) and long term (1 year). The imaging agent will be provided by AVID. Furthermore the study will standardize imaging studies using florbetapir F 18 PET to provide information on amyloid burden.
Interventions
- DIAGNOSTIC_TEST PET scan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2013-04 |
| Est. Completion | 2017-10 |
Why NCT01834625 stopped before completion
NCT01834625 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 2 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which PET scan is the first listed.
NCT01834625 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01834625 about?
NCT01834625 is a clinical study titled "Prognostic Value of Aβ Imaging in NPH Prior to Shunt Placement". In this pilot study the investigators shall prospectively in a blinded fashion evaluate with Aβ PET in patients committed to shunt surgery and then investigate the relationship of these biomarkers with outcome on gait, cognition and urinary control improvement in the short term (3 months) and long t...
What is the current status of trial NCT01834625?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2013-04. Estimated completion is 2017-10.
What interventions are being tested in trial NCT01834625?
The interventions under investigation include: PET scan (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT01834625?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia